BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2834001)

  • 1. An endogenous substance with clonidine-like properties: selective binding to imidazole sites in the ventrolateral medulla.
    Ernsberger P; Meeley MP; Reis DJ
    Brain Res; 1988 Feb; 441(1-2):309-18. PubMed ID: 2834001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance.
    Ernsberger P; Feinland G; Meeley MP; Reis DJ
    Am J Hypertens; 1990 Feb; 3(2):90-7. PubMed ID: 2155003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla.
    Ernsberger P; Meeley MP; Mann JJ; Reis DJ
    Eur J Pharmacol; 1987 Jan; 134(1):1-13. PubMed ID: 3030779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla.
    Meeley MP; Ernsberger PR; Granata AR; Reis DJ
    Life Sci; 1986 Mar; 38(12):1119-26. PubMed ID: 3007903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha-2-adrenergic receptors in the rostral ventrolateral medulla.
    Ernsberger P; Giuliano R; Willette RN; Granata AR; Reis DJ
    J Hypertens Suppl; 1988 Dec; 6(4):S554-7. PubMed ID: 2853758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonidine-specific antibodies as models for imidazole and alpha 2-adrenergic receptor binding sites: implications for the structure of clonidine-displacing substance.
    Meeley MP; Ernsberger P; McCauley PM; Reis DJ
    J Hypertens Suppl; 1988 Dec; 6(4):S490-3. PubMed ID: 2467973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of [3H]p-aminoclonidine to two sites, alpha 2-adrenoceptors and imidazoline binding sites: distribution of imidazoline binding sites in rat brain.
    Kamisaki Y; Ishikawa T; Takao Y; Omodani H; Kuno N; Itoh T
    Brain Res; 1990 Apr; 514(1):15-21. PubMed ID: 2162708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
    Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla.
    Ernsberger P; Giuliano R; Willette RN; Reis DJ
    J Pharmacol Exp Ther; 1990 Apr; 253(1):408-18. PubMed ID: 2158551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of the use of [3H]-clonidine to identify imidazoline receptors in the rabbit brainstem.
    Bricca G; Zhang J; Greney H; Dontenwill M; Stutzmann J; Belcourt A; Bousquet P
    Br J Pharmacol; 1993 Dec; 110(4):1537-43. PubMed ID: 8306099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area.
    Gomez RE; Ernsberger P; Feinland G; Reis DJ
    Eur J Pharmacol; 1991 Mar; 195(2):181-91. PubMed ID: 1651861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An endogenous brain substance, CDS (clonidine-displacing-substance), inhibits the twitch response of rat vas deferens.
    Diamant S; Atlas D
    Biochem Biophys Res Commun; 1986 Jan; 134(1):184-90. PubMed ID: 3004427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors.
    Piletz JE; Chikkala DN; Ernsberger P
    J Pharmacol Exp Ther; 1995 Feb; 272(2):581-7. PubMed ID: 7853171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of non-adrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal medulla.
    Regunathan S; Meeley MP; Reis DJ
    Biochem Pharmacol; 1993 Apr; 45(8):1667-75. PubMed ID: 8387303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    Pinthong D; Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine-displacing substance and agmatine.
    Reis DJ; Li G; Regunathan S
    Ann N Y Acad Sci; 1995 Jul; 763():295-313. PubMed ID: 7677340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human brain imidazoline receptors: further characterization with [3H]clonidine.
    Bricca G; Greney H; Zhang J; Dontenwill M; Stutzmann J; Belcourt A; Bousquet P
    Eur J Pharmacol; 1994 Jan; 266(1):25-33. PubMed ID: 8137880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and partial purification of a clonidine-displacing endogenous brain substance.
    Atlas D; Burstein Y
    Eur J Biochem; 1984 Oct; 144(2):287-93. PubMed ID: 6092070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of an endogenous clonidine-displacing substance from rat brain.
    Atlas D; Burstein Y
    FEBS Lett; 1984 May; 170(2):387-90. PubMed ID: 6327389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.